We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Hydrogel Could Become Bone Implant of the Future

By HospiMedica International staff writers
Posted on 04 Mar 2026

Bone fractures often heal naturally, but severe injuries or bone tumors may require surgical implants to restore stability and promote healing. More...

Current solutions typically involve autografts using the patient’s own bone or rigid metal implants. Autografts require additional surgery to harvest tissue, while metal implants can be overly stiff and may loosen over time. These limitations have driven research into biomaterials that better mimic natural bone healing. Researchers have now developed a soft hydrogel material designed to support bone regeneration while gradually dissolving in the body.

The new hydrogel biomaterial, developed by researchers at ETH Zurich (Zurich, Switzerland), contains 97 percent water and 3 percent biocompatible polymer and is engineered to replicate the early stages of natural bone healing. To shape the material, scientists introduced a specialized linking molecule that binds polymer chains when exposed to laser light. This allows precise laser printing of complex structures within the hydrogel. The technology can produce nanoscale features as small as 500 nanometers, enabling the creation of bone-like networks that mimic the trabecular architecture found in natural bone.

Using high-speed laser structuring, the researchers created hydrogel scaffolds based on medical imaging of real bone structures. The system achieved writing speeds of up to 400 millimeters per second, enabling extremely fine and stable structuring of the soft material. The findings of laboratory tests, published in Advanced Materials, showed that bone-forming cells rapidly colonized the hydrogel and began producing collagen, an essential component of bone tissue. The experiments also confirmed that the material is biocompatible and does not damage the cells.

The hydrogel scaffold could serve as a personalized implant that gradually dissolves while guiding bone regeneration. Because the material mimics the body’s natural healing process, it may provide a more biologically compatible alternative to rigid implants. The researchers have patented the material and plan to conduct animal studies. These future experiments will examine whether the hydrogel supports bone regeneration and restores mechanical strength in living organisms.

“Hydrogels resemble jelly, making them difficult to shape,” said ETH Professor Xiao-Hua Qin. “With our newly developed connecting molecule, we can now not only structure the hydrogel in a stable and extremely fine manner but also produce it at high writing speeds of up to 400 millimeters per second. That’s a new world record.”

Related Links:
ETH Zurich


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.